Breast Implant helpline Louisiana and Breast Implant lawyers are here to help you with all aspects of your breast implant claim.
Get help with deficiency notices, proof of manufacturer and proof of disease diagnosis for Alexandria, Baton Rouge, Houma, Lafayette, Lake Charles, Monroe, New Orleans, Shreveport and all of Louisiana.
Silicone Breast Implant Overview
Between 5 million and 10 million women have breast implants worldwide.
Dangers of Silicone Breast Implants
Silicone and its contaminants which bleed through its surrounding implant envelope into neighboring tissue have the potential for significant toxicity in the implant recipient. Silicone elicits antibody responses and immunological abnormalities.
Typical symptoms associated with silicone illness (also called “silicone poisoning” or “silicosis”) include cognitive dysfunction, short-term memory loss, Sjogren’s syndrome (dryness in the glands, such as the mouth, kidneys, eyes, and lungs), scleroderma, rheumatoid arthritis, dermatom-yositis, severe joint and muscle pain, incapacitating fatigue, swollen lymph glands, skin problems, peripheral numbness, multiple allergies, headaches, hair loss, sunlight sensitivity, central nervous system disorders (similar to multiple sclerosis), and others.
Symptoms Associated with breast Implants
- Breast Pain
- Upper and Lower Back Pain
- Chemical Sensitivities
- Muscle Pain, Stiffness, Unusual Fatigue
- Excessive Hair Loss
- Achy or Swollen Joints
- Extreme fatigue
- Skin Rashes
- Sensitivity to Sunlight
- Kidney Problems
- Difficulty Swallowing or Breathing
Diseases from Silicone breast Implants
- Neurological Diseases
- Rheumatological Problems
- Autoimmune Diseases
- Chronic Fatigue Syndrome
- Esophogeal Immotility
- Raynaud’s Syndrome
- Multiple Sclerosis Like Symptoms
- General Connective Tissue Diseases
- Systemic Fungus
- Sjogren’s Syndrome
Lupus and Breast Implants
Breast Implants Linked to Cancer
(FDA) has advised that breast implants, whether composed of saline or silicone, are linked to Anaplastic Large Cell Lymphoma (ALCL), a cancer of the immune system. It issued a breast implant warning in the form of a safety communication on its web site.
Symptoms of breast implant lymphoma include:
- Asymmetry that developed after their initial surgical sites were fully healed
These symptoms were due to collection of fluid (peri-implant seroma), hardening of breast area around the implant (capsular contracture), or masses surrounding the breast implant. Examination of the fluid and capsule surrounding the breast implant led to the ALCL diagnosis, the FDA said.
ALCL is a rare malignant tumor (non-Hodgkin lymphoma) that may appear in several parts of the body including the lymph nodes, skin, bones, soft tissue, lungs or liver. Each year ALCL is diagnosed in about 1 out of 500,000 women in the United States. ALCL located in breast tissue is found in only about 3 out of every 100 million women nationwide without breast implants.
If you believe you may have a problem or disease relating to defective breast implants, it is recommended to contact an experienced Lupus physician who can make a l diagnosis. This proof of disease diagnosis will help your breast implant claim.
Dow Corning trust Payments
Any approved disease in Disease Option 1 with a Severity or Disability Level of A, B, C, or D To be eligible for this, you must have proof that you have or had one or more Dow Corning breast implants and have not had a Bristol, Baxter or 3M silicone gel breast implant **
Severity / Disability Level Base Payment Premium Payment Total Payment
Level A $50,000 $10,000 $60,000
Level B $20,000 $4000 $24,000
Level C $10,000 $2000 $12,000
** If you have acceptable proof that you have or had a Bristol, Baxter, or 3M silicone gel breast implant, the Total Payment Amount will be reduced by 50%.
There are many different types of disease that fall under the guidelines of the Class Action. Different levels of compensation are available for specific disease and diagnoses’. Some of them are: Lupus (SLE), autoimmune disease, dry eyes, dry mouth; polyarthritis, skin rashes, face rashes, numbness and tingling in hands and toes (neuropathy), chronic fatigue, fibromyalgia, myalgia, or abnormal blood work.
In 1991, Dow Corning manufactured an sold more that 4,500 silicone-based products to 45,000 customers worldwide, and was considered a leader in the industry. About 1% of total sales in 1991 came from silicone breast implant product.
June 3, 2019 Deadline To Submit Disease Or Expedited Release Claim
If you are registered with the SF-DCT and have not submitted your disease claim, contact our the Dow Corning Breast Implant Helpline for an explanation of the benefits available to you.
Dow Corning/SF-DCT Registration deadline has passed. If you are not sure of your status, you owe it to yourself to call us and find out about your rights within the SF-DCT.
There is no obligation to use our services, and YOU PAY NO FEE UNLESS YOU ARE AWARDED A SETTLEMENT.
Status Of Premium Payments
We do not have an update on when the Finance Committee will make a recommendation to pay the partial Premium Payments to claimants whose payment was stopped because of the ruling by the Court of Appeals for the Sixth Circuit. The Claimant Advisory Committee strongly believes – and has urged the Finance Committee – that these payments should be made immediately. We believe they will file a recommendation with the Court sometime this year. Once a recommendation is filed, the District Court must still approve it.
There is no update on when the final 50% Premium Payment will be made.
Increased Severity Claims
The Claims Office is now accepting claim filings for “Increased Severity”. You may qualify for an additional settlement if:
Your disease claim was approved in Disease Option 1 (such as ACTD or ANDS disease claims), AND your disease now qualifies for Severity Level A (100% total disability);
Your disease claim was approved in Disease Option 2. You can apply for an Increased Severity Level if you now have a disease or condition that qualifies for a higher level payment.
The deadline to file for Increased Severity claims is June 3, 2019.